metformin and glp-1 together Disproportionality analysis of receptor agonists combined with based on the FAERS database Is It Time to Change

Available at: Jastreboff AM, Aronne LJ, Ahmad NN, et al

JAMA 2021;325:141425

The associated caloric loss also contributes to reductions in body weight by 2 to 3 kg on average, another traditional CV risk factor [15,17]

Repeated weight cycling often results from biological adaptation rather than personal failure

Nutritional Risks of Combining Fasting and GLP-1 Therapy The biggest risk when merging intermittent fasting with GLP-1 use is consuming too few calories during eating windows, leading to protein deficiency, micronutrient gaps, and loss of lean muscle mass

In Brazil, the number is likely to be high as well, since it's the country that performs the second most bariatric surgeries in the world," the researcher emphasises